Vascular Endothelial Growth Factor A Isoform mRNA Expression in Pediatric Acute Myeloid Leukemia

被引:8
|
作者
Kruizinga, R. C. [1 ,2 ]
de Jonge, H. J. M. [1 ]
Kampen, K. R. [1 ]
Walenkamp, A. M. E. [2 ]
de Bont, E. S. J. M. [1 ]
机构
[1] Univ Groningen, Div Pediat Oncol Hematol, Dept Pediat,Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Dept Med Oncol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
关键词
AML; isoform; VEGFA; SPLICE VARIANTS; VEGF-A; AML; 10; SURVIVAL; ANGIOGENESIS; TUMORS;
D O I
10.1002/pbc.22783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In AML high VEGFA protein expression correlates with poor overall and relapse-free survival (OS/RFS). To date, the relevance of the various VEGFA isoforms is unclear. We determined VEGF121, VEGF145, VEGF148, VEGF165, VEGF183, and VEGF189 mRNA expression in pediatric AML samples and investigated the relation between VEGFA isoform expression and clinicopatholologic characteristics and outcome. A significant co-expression of VEGF121, VEGF165, VEGF183, and VEGF189 isoforms was apparent (mean rho = 0.716, P<0.0001). This co-expression justifies measuring a single VEGFA isoform (e.g., 121, 165, 183, and 189) as representative expression of all VEGFA isoforms in future studies designed to determine the prognostic importance of VEGFA isoforms. Pediatr Blood Cancer 2011;56:294-297. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:294 / 297
页数:4
相关论文
共 50 条
  • [1] Vascular endothelial growth factor 121 (VEGF121) isoform mRNA is predictive of poor prognosis in acute myeloid leukemia (AML).
    Calvo, F
    Rousselot, P
    Dombret, H
    Medioni, J
    Mourah, S
    BLOOD, 2004, 104 (11) : 554A - 554A
  • [2] Vascular endothelial growth factor signaling in acute myeloid leukemia
    Kim R. Kampen
    Arja ter Elst
    Eveline S. J. M. de Bont
    Cellular and Molecular Life Sciences, 2013, 70 : 1307 - 1317
  • [3] Vascular endothelial growth factor signaling in acute myeloid leukemia
    Kampen, Kim R.
    ter Elst, Arja
    de Bont, Eveline S. J. M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (08) : 1307 - 1317
  • [4] Vascular endothelial growth factor expression in acute myeloid leukemia: a biomarker ready for primetime?
    Levine, Ross L.
    LEUKEMIA & LYMPHOMA, 2013, 54 (07) : 1345 - 1346
  • [5] Differentiated Expression of microRNAs May be Regulated By the Vascular Endothelial Growth Factor in Acute Myeloid Leukemia
    Ye, Xiujin
    Zhu, Lixia
    BLOOD, 2014, 124 (21)
  • [6] The role of vascular endothelial growth factor signaling in pediatric acute leukemia
    Macy, Margaret
    Gore, Lia
    DeRyckere, Deborah
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3597S - 3597S
  • [7] Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
    Fiedler, W
    Graeven, U
    Ergun, S
    Verago, S
    Kilic, N
    Stockschlader, M
    Hossfeld, DK
    BLOOD, 1997, 89 (06) : 1870 - 1875
  • [8] Repression of Vascular Endothelial Growth Factor Expression by the Runt-Related Transcription Factor 1 in Acute Myeloid Leukemia
    ter Elst, Arja
    Ma, Bin
    Scherpen, Frank J. G.
    de Jonge, Hendrik J. M.
    Douwes, Jenny
    Wierenga, Albertus T. J.
    Schuringa, Jan Jacob
    Kamps, Willem A.
    de Bont, Eveline S. J. M.
    CANCER RESEARCH, 2011, 71 (07) : 2761 - 2771
  • [9] Expression of vascular endothelial growth factor and its receptors in the bone marrow of patients with acute myeloid leukemia.
    Padró, T
    Bieker, R
    Ruiz, S
    Hintelmann, H
    Kienast, J
    Büchner, T
    Berdel, WE
    Mesters, RM
    BLOOD, 2000, 96 (11) : 103A - 103A
  • [10] Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
    Aguayo, A
    Estey, E
    Kantarjian, H
    Mansouri, T
    Gidel, C
    Keating, M
    Giles, F
    Estrov, Z
    Barlogie, B
    Albitar, M
    BLOOD, 1999, 94 (11) : 3717 - 3721